In a Q&A, NIH addiction chief Nora Volkow speaks about RFK Jr.'s policy shake-ups, 12-step recovery limits, and why overdose deaths are falling.
Move came just hours before Weldon, a former congressman and long-time vaccine critic, was to appear at his Senate confirmation hearing.
Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.
In this week's edition of "Adam's Biotech Scorecard," let’s give "biotech gloom" a rest and lead off with something hopeful for patients and investors.
Cage Pharma executives say they see promise in the therapy — 3-bromopyruvate or 3BP — despite a troubled history.
HIV self-testing is convenient, people like it, and it’s recommended by the CDC — so why does uptake remain so low?
The threats among early career researchers should be concerning to all who care about the future of American science and research leadership.
